Previous 10 | Next 10 |
home / stock / dsnky / dsnky news
2023-10-19 23:52:31 ET More on Daiichi, Merck, etc. Merck: Right On Time Merck Vs. GSK: The Game-Changer Race In Pharma Excellence Merck: Still Fundamentally Undervalued Considering Keytruda's Prospects AstraZeneca drops after Phase 3 data for lung cancer the...
2023-10-18 10:25:26 ET More on AstraZeneca, Daiichi, etc. AstraZeneca: Hidden Gem Of The Pharma Sector Is A Great Buy Opportunity AbbVie Vs. AstraZeneca: Battle Of The Pharmaceutical Behemoths Daiichi Sankyo Company, Limited (DSKYF) Q1 2023 Earnings Call Transcript ...
2023-10-13 11:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A historically wide di...
2023-09-22 07:25:38 ET More on AstraZeneca Seeking Alpha’s Quant Rating on AstraZeneca Historical earnings data for AstraZeneca AbbVie Vs. AstraZeneca: Battle Of The Pharmaceutical Behemoths AstraZeneca: Robust Performance And Promising Growth Initiati...
2023-09-15 11:05:45 ET More on Lilly, Ascendis, and Novartis Eli Lilly: A Potential Game Changer For Weight Management And Cardiovascular Health Ascendis Pharma: Revenue Promise Meets Cash Flow Challenge Sandoz to commercialize biosimilar to J&J blockbuster drug ...
2023-09-03 03:45:00 ET Summary Shanghai GenFleet Technologies partners with Verastem in a deal worth up to $625.5 million for three preclinical small-molecule candidates for RAS pathway-driven cancers. Shanghai Kangpu Biopharmaceuticals raises $13.8 million in a B funding round to...
2023-08-31 09:58:25 ET More on AstraZeneca AstraZeneca: Robust Performance And Promising Growth Initiatives AstraZeneca's Q2 Earnings Exceed Expectations, Astonishing Investors (Rating Upgrade) AstraZeneca: Solid Earnings Report Reinforces Medium To Long-Term Upside ...
2023-08-01 13:32:44 ET More on Daiichi Sankyo Daiichi Sankyo Company, Limited ( OTCPK:DSKYF ) Q1 2023 Earnings Call Transcript Shionogi & Co., Ltd. ( OTCPK:SGIOF ) Q1 2023 Earnings Call Transcript Daiichi Sankyo: There Is A Lot Of Room To Grow Dai...
2023-07-31 22:12:02 ET Daiichi Sankyo Company, Limited (DSKYF) Q1 2023 Earnings Conference Call July 31, 2023, 2:00 AM ET Company Participants Kentaro Asakura - Vice President of Corporate Communications Department Koji Ogawa - Executive Officer and Chief Financial O...
2023-07-13 11:15:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Japan drove internatio...
News, Short Squeeze, Breakout and More Instantly...
Daiichi Sankyo Co Ltd Sponsored ADR Level 1 Company Name:
DSNKY Stock Symbol:
OTCMKTS Market:
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig PR Newswire Phase 3 trial evaluating rilvegostomig as monotherapy and in combination with AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan in ...
2023-10-31 10:15:00 ET Big pharmas have the resources to make big, multi-year moves that can reshape or even redefine their businesses. As you may know, Merck (NYSE: MRK) is one of the largest of the big pharmas, with a market capitalization of $262 billion, and it just made one of ...
Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceutical Packaging PR Newswire TOKYO and OSAKA, Japan , Dec. 21, 2022 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO:...